Author:
Zuanelli Brambilla Corrado,Lobaugh Stephanie M.,Ruiz Josel D.,Dahi Parastoo B.,Goldberg Aaron D.,Young James W.,Gyurkocza Boglarka,Shaffer Brian C.,Ponce Doris M.,Tamari Roni,Sanchez Escamilla Miriam,Castillo Flores Nerea,Politikos Ioannis,Scordo Michael,Shah Gunjan L.,Cho Christina,Lin Richard J.,Maloy Molly A.,Devlin Sean M.,Jakubowski Ann A.,Berman Ellin,Stein Eytan M.,Papadopoulos Esperanza B.,Perales Miguel-Angel,Tallman Martin S.,Giralt Sergio A.,Smith Melody
Funder
NIH
Damon Runyon Cancer Research Foundation
Italian Association for Cancer Research
Italian Association Against Leukemia-Lymphoma and Myeloma ONLUS
Burroughs Wellcome Fund
American Society of Hematology
Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference39 articles.
1. Phelan R, Arora M, Chen M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2020. Available at: https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/Documents/US%202020%20Summary%20Slides%20-%20final%20-%20for%20web%20posting.pptx. Accessed June 24th 2021.
2. Relapse after allogeneic stem cell transplantation;Barrett;Expert Rev Hematol,2010
3. Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation;Bejanyan;Bone Marrow Transplant,2014
4. Chemotherapy versus hypomethylating agents for the treatment of relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplant;Motabi;Biol Blood Marrow Transplant,2016
5. 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis;Czibere;Bone Marrow Transplant,2010